SFZN Siegfried Holding AG

80.04USD67.45 CHF · SWX-0.44%Mkt Cap: 3.51B USDP/E: 17.25

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including …

Institutional holders10 on file

Key Statistics

Company
Market Cap3.51B USD
Enterprise Value4.49B USD
Revenue (TTM)1.59B USD
Gross Profit420.06M USD
Net Income (TTM)200.14M USD
Revenue/Share36.24 USD
Last Price80.04 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.5K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCH1429326825
Valuation
P/E (Trailing)17.25
P/E (Forward)14.44
PEG1.27
EV/EBITDA11.95
EV/Revenue2.82
P/S2.20
P/B2.98
EPS (TTM)4.64 USD
EPS (Forward)5.54 USD
52W Range
77.197% of range120.56
52W High120.56 USD
52W Low77.19 USD
Profitability
Gross Margin26.66%
Oper. Margin16.71%
EBITDA Margin23.60%
Profit Margin12.70%
ROE14.95%
ROA7.83%
ROIC—
ROCE13.28%
Growth
Revenue Growth2.20%
Earnings Growth4.00%
Cash Flow & Leverage
Operating CF270.74M USD
CapEx (TTM)274.67M USD
FCF Margin-10.27%
FCF Yield-4.66%
Net Debt973.08M USD
Net Debt/EBITDA2.59
Net Debt/FCF—
Balance Sheet
Debt/Equity93.09
Current Ratio3.45
Quick Ratio1.36
Book Value/Sh26.87 USD
Cash/Share2.84 USD
Dividends
Fwd Div Rate0.47 USD
Trail. Div Rate0.47 USD
Div. Yield0.59%
5Y Avg Yield0.43%
Payout Ratio10.26%
Ex-Div DateApr 28, 2026
Pay DateApr 24, 2025
Splits
Last Split10:1
Split DateApr 28, 2025
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)117.38 USD
Upside (mean)+46.7%
Target Range90.18 USD – 166.13 USD
90.18+46.7% to mean166.13
# Analysts12
Ownership
Shares Out.43.81M
Float39.90M
Insiders13.23%
Institutions51.66%
Technical
SMA 5084.82 (-5.6%)
SMA 20090.11 (-11.2%)
Beta0.78
S&P 52W Chg12.00%
Avg Vol (30d)101.53K
Avg Vol (10d)103.12K
Technical Indicators
RSI (14)34.6
MACD-0.8949
MACD Signal-0.3288
MACD Hist.-0.5661
BB Upper89.96 USD
BB Middle84.85 USD
BB Lower79.74 USD
BB Width12.04%
ATR (14)2.116 USD
Vol Ratio (20d)1.03x

About Siegfried Holding (SWX: SFZN)

›

Siegfried Holding (SWX: SFZN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 4,454 employees.

The shares were at 67.45 CHF on 19 November 2026, down 11.5% over 52 weeks. Its 52-week range is 65.05 CHF to 101.60 CHF: the price is 33.6% below the high and 3.7% above the low.

At a market capitalisation of 2.95B CHF, it trades at 17.3 times trailing earnings and 14.4 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 30% for SFZN. It pays a dividend yielding 0.59% (it pays out 10% of its earnings), against a median of 1.90% among the dividend payers in that peer group.

Siegfried Holding reports return on equity of 15.0%, an operating margin of 16.7% and revenue up 2.2% year over year.

Its debt exceeds its cash by 820.04M CHF. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 98.92 CHF is 46.7% above the current price. The next earnings report is expected on 23 February 2027.